Collecalciferol as an Add-on Treatment to Subcutaneously-Administred I
Collecalciferol as an Add-on Treatment to Subcutaneously-Administred Interferon-beta-1b for Treatment MS
What was tested
Treatment tested
- Cholecalciferol
Vitamin D receptor agonist
Placebo
- Placebo Dekristol SGC 20000
Papers
Results
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.J Neurol Neurosurg Psychiatry · 2012
Loading reviews and guidelines…
Related trials
- Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
Not a drug-phase study · Completed
No results found
- Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy
Not a drug-phase study · Status unknown
No results found
- Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
Phase 4 · Status unknown
No results found
- Efficacy of Diet on Quality of Life in Multiple Sclerosis
Not a drug-phase study · Running, not recruiting
Still running
- Prebiotic vs Probiotic in Multiple Sclerosis
Not a drug-phase study · Completed
Paper found, not read
- Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance
Not a drug-phase study · Status unknown
No results found
History
- In scope changed from true to false
Started
Dec 2007
Assembled by software from public sources.